T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

By E. Klyushnenkova, J. Mosca, V. Zernetkina, M. Majumdar, K. Beggs, D. Simonetti, R. Deans, K. Mcintosh. Journal of Biomedical Sciences, 2005

602 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Immunology

View Paper: https://www.semanticscholar.org/paper/ab7f435d653827b16cb781f78e24a9d110c2fff8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. O. Ringdén
2. A. Caplan
3. W. Fibbe

In Hematology

1. O. Ringdén

Citations in the corpus

• Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs (2019, background): “It has been demonstrated that allogenic MSCs can activate T cells (89, 93).”
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease (2006, background): “Human MSC are suppressive when MSC and lymphocytes are separated in a transwell system, whereas rodent MSC requires cell-cell contact (26, 28, 29, 31, 33).”